BIOMAT Database Logo BIOMAT Database Logo

Paroxysmal nocturnal hemoglobinuria with myelofibrosis: progression to acute myeloblastic leukemia. 1993

J Nakahata, and M Takahashi, and I Fuse, and Y Nakamori, and N Nomoto, and H Saitoh, and W Tatewaki, and A Imanari, and T Takeshige, and T Koike
First Department of Internal Medicine, Niigata University, School of Medicine, Japan.

A 58-year-old male was diagnosed as having paroxysmal nocturnal hemoglobinuria (PNH) with myelofibrosis in 1984. The administration of hydroxyurea and low dose splenic irradiation were initiated for abdominal distention due to splenomegaly in 1987. In May 1990 the patient developed smouldering acute myeloblastic leukemia (AML); and the blasts proliferated in response to G-CSF administered for refractory pneumonia. The patient died of pneumonia and pleural involvement of leukemia in September 1990. FACS analysis of the blasts using anti-decay accelerating factor (DAF) (CD55) and CD59 (membrane attack complex inhibition factor: MACIF) monoclonal antibodies demonstrated that 25.5% and/or 87.3% of the blasts were negative for DAF or CD59 respectively. There is the earlier evidence that about 90% leukemic myeloblasts from non-PNH AML patients are positive for DAF, and nearly 100% of non-PNH neutrophils have been shown to be positive for both DAF and CD59. Our data suggest that the leukemic blasts from this patient may have derived from the PNH clone.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006457 Hemoglobinuria, Paroxysmal A condition characterized by the recurrence of HEMOGLOBINURIA caused by intravascular HEMOLYSIS. In cases occurring upon cold exposure (paroxysmal cold hemoglobinuria), usually after infections, there is a circulating antibody which is also a cold hemolysin. In cases occurring during or after sleep (paroxysmal nocturnal hemoglobinuria), the clonal hematopoietic stem cells exhibit a global deficiency of cell membrane proteins. Paroxysmal Cold Hemoglobinuria,Paroxysmal Nocturnal Hemoglobinuria,Marchiafava-Micheli Syndrome,Paroxysmal Hemoglobinuria,Paroxysmal Hemoglobinuria, Cold,Paroxysmal Hemoglobinuria, Nocturnal,Cold Paroxysmal Hemoglobinuria,Hemoglobinuria, Cold Paroxysmal,Hemoglobinuria, Nocturnal Paroxysmal,Hemoglobinuria, Paroxysmal Cold,Hemoglobinuria, Paroxysmal Nocturnal,Marchiafava Micheli Syndrome,Nocturnal Paroxysmal Hemoglobinuria,Syndrome, Marchiafava-Micheli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006918 Hydroxyurea An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. Hydroxycarbamid,Hydrea,Oncocarbide

Related Publications

J Nakahata, and M Takahashi, and I Fuse, and Y Nakamori, and N Nomoto, and H Saitoh, and W Tatewaki, and A Imanari, and T Takeshige, and T Koike
Paroxysmal nocturnal hemoglobinuria terminating in acute myeloblastic leukemia.
February 1969, Blood,
J Nakahata, and M Takahashi, and I Fuse, and Y Nakamori, and N Nomoto, and H Saitoh, and W Tatewaki, and A Imanari, and T Takeshige, and T Koike
Acute myeloblastic leukemia in paroxysmal nocturnal hemoglobinuria. Evidence of evolution from the abnormal paroxysmal nocturnal hemoglobinuria clone.
January 1987, The Journal of clinical investigation,
J Nakahata, and M Takahashi, and I Fuse, and Y Nakamori, and N Nomoto, and H Saitoh, and W Tatewaki, and A Imanari, and T Takeshige, and T Koike
Paroxysmal nocturnal hemoglobinuria with acute leukemia.
February 1969, Blood,
J Nakahata, and M Takahashi, and I Fuse, and Y Nakamori, and N Nomoto, and H Saitoh, and W Tatewaki, and A Imanari, and T Takeshige, and T Koike
Paroxysmal nocturnal hemoglobinuria in myelofibrosis.
October 1970, Blood,
J Nakahata, and M Takahashi, and I Fuse, and Y Nakamori, and N Nomoto, and H Saitoh, and W Tatewaki, and A Imanari, and T Takeshige, and T Koike
[A case of myelofibrosis with paroxysmal nocturnal hemoglobinuria].
July 1973, [Rinsho ketsueki] The Japanese journal of clinical hematology,
J Nakahata, and M Takahashi, and I Fuse, and Y Nakamori, and N Nomoto, and H Saitoh, and W Tatewaki, and A Imanari, and T Takeshige, and T Koike
Paroxysmal nocturnal hemoglobinuria terminating in acute granulocytic leukemia.
February 1969, Blood,
J Nakahata, and M Takahashi, and I Fuse, and Y Nakamori, and N Nomoto, and H Saitoh, and W Tatewaki, and A Imanari, and T Takeshige, and T Koike
Myeloblastic leukemoid reaction in paroxysmal nocturnal hemoglobinuria associated with myelodysplasia.
January 1992, Acta haematologica,
J Nakahata, and M Takahashi, and I Fuse, and Y Nakamori, and N Nomoto, and H Saitoh, and W Tatewaki, and A Imanari, and T Takeshige, and T Koike
Paroxysmal nocturnal hemoglobinuria terminating in TdT-positive acute leukemia.
February 1983, American journal of hematology,
J Nakahata, and M Takahashi, and I Fuse, and Y Nakamori, and N Nomoto, and H Saitoh, and W Tatewaki, and A Imanari, and T Takeshige, and T Koike
Sequels to chloramphenicol aplastic anemia: acute leukemia and paroxysmal nocturnal hemoglobinuria.
September 1969, Northwest medicine,
J Nakahata, and M Takahashi, and I Fuse, and Y Nakamori, and N Nomoto, and H Saitoh, and W Tatewaki, and A Imanari, and T Takeshige, and T Koike
Leukemia evolving from paroxysmal nocturnal hemoglobinuria.
January 2020, Leukemia,
Copied contents to your clipboard!